| 000 | 01848 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515191324.0 | ||
| 264 | 0 | _c20100401 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1528-0012 | ||
| 024 | 7 |
_a10.1053/j.gastro.2009.09.056 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaert, Filip | |
| 245 | 0 | 0 |
_aMucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. _h[electronic resource] |
| 260 |
_bGastroenterology _cFeb 2010 |
||
| 300 |
_a463-8; quiz e10-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xphysiopathology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWound Healing _xphysiology |
| 700 | 1 | _aMoortgat, Liesbeth | |
| 700 | 1 | _aVan Assche, Gert | |
| 700 | 1 | _aCaenepeel, Philip | |
| 700 | 1 | _aVergauwe, Philippe | |
| 700 | 1 | _aDe Vos, Martine | |
| 700 | 1 | _aStokkers, Pieter | |
| 700 | 1 | _aHommes, Daniel | |
| 700 | 1 | _aRutgeerts, Paul | |
| 700 | 1 | _aVermeire, Severine | |
| 700 | 1 | _aD'Haens, Geert | |
| 773 | 0 |
_tGastroenterology _gvol. 138 _gno. 2 _gp. 463-8; quiz e10-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2009.09.056 _zAvailable from publisher's website |
| 999 |
_c19212573 _d19212573 |
||